1700EGP
- Active ingredient
- sacubitril+valsartan
- Strength
- 100 mg + 49/51 mg
- Form
- tablet
- Manufacturer
- novartis
- Route
- oral.solid
Uses
Used to reduce cardiovascular death and hospitalization in chronic heart failure and to treat symptomatic heart failure in eligible pediatric patients.
Do not use if
History of angioedema related to ACE inhibitors or ARBs, concomitant ACE inhibitor use, or hypersensitivity.
Side effects
Hypotension, hyperkalemia, dizziness, impaired renal function, and angioedema may occur.
Warnings
Contraindicated during pregnancy due to fetal toxicity. Monitor renal function and potassium levels.
How it works
Combines neprilysin inhibition with angiotensin II receptor blockade to improve cardiovascular outcomes.
Storage
Store at room temperature.
